Item Type | Name |
Concept
|
Acute Disease
|
Concept
|
Adenocarcinoma
|
Concept
|
Acetylation
|
Concept
|
Antibodies, Neoplasm
|
Concept
|
Binding Sites, Antibody
|
Concept
|
Breast Neoplasms
|
Concept
|
Amino Acid Sequence
|
Concept
|
Antigens, Differentiation
|
Concept
|
Antigens, Surface
|
Concept
|
Antineoplastic Agents
|
Concept
|
Apolipoproteins E
|
Concept
|
Busulfan
|
Concept
|
Aneuploidy
|
Concept
|
Animals
|
Concept
|
Animals, Newborn
|
Concept
|
Antifungal Agents
|
Concept
|
Antimetabolites, Antineoplastic
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
Concept
|
Antiviral Agents
|
Concept
|
Chromosomes, Human, Pair 6
|
Concept
|
Analysis of Variance
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Ascorbic Acid
|
Concept
|
Arabinonucleosides
|
Concept
|
B-Lymphocytes
|
Concept
|
Base Sequence
|
Concept
|
Benzamides
|
Concept
|
Cell Movement
|
Concept
|
DNA Damage
|
Concept
|
Bromelains
|
Concept
|
Azacitidine
|
Concept
|
Binding Sites
|
Concept
|
Blood Grouping and Crossmatching
|
Concept
|
California
|
Concept
|
Cell Division
|
Concept
|
Colon
|
Concept
|
Colonic Neoplasms
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Uterine Cervical Neoplasms
|
Concept
|
Chromosome Deletion
|
Concept
|
Chromosomes, Human, Pair 22
|
Concept
|
Burkitt Lymphoma
|
Concept
|
Chromosomes, Human, Pair 5
|
Concept
|
Chromosomes, Human, Pair 7
|
Concept
|
C-Reactive Protein
|
Concept
|
Cocarcinogenesis
|
Concept
|
Hepatic Veno-Occlusive Disease
|
Concept
|
Colony-Forming Units Assay
|
Concept
|
DNA-Binding Proteins
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Leukemia, Erythroblastic, Acute
|
Concept
|
DNA Repair
|
Concept
|
Drosophila
|
Concept
|
Cause of Death
|
Concept
|
DNA Mutational Analysis
|
Concept
|
DNA, Neoplasm
|
Concept
|
Cyclophosphamide
|
Concept
|
Europe
|
Concept
|
Glucocorticoids
|
Concept
|
Graft Survival
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Leukemia
|
Concept
|
Chromosomes, Human, Pair 9
|
Concept
|
Mammary Neoplasms, Experimental
|
Concept
|
Expert Testimony
|
Concept
|
Cytarabine
|
Concept
|
Disease Susceptibility
|
Concept
|
DNA
|
Concept
|
DNA Topoisomerases, Type II
|
Concept
|
Infant, Newborn
|
Concept
|
Introns
|
Concept
|
Methyltransferases
|
Concept
|
Muscle Hypotonia
|
Concept
|
Glioma
|
Concept
|
Glioblastoma
|
Concept
|
Feasibility Studies
|
Concept
|
Fibroblast Growth Factors
|
Concept
|
Karyotyping
|
Concept
|
Graft Rejection
|
Concept
|
DNA (Cytosine-5-)-Methyltransferases
|
Concept
|
Hippocampus
|
Concept
|
Heart
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Hydrogen Peroxide
|
Concept
|
Histocompatibility Testing
|
Concept
|
Hydroxamic Acids
|
Concept
|
Flow Cytometry
|
Concept
|
Fluorescent Antibody Technique
|
Concept
|
Inflammation
|
Concept
|
Infusions, Intravenous
|
Concept
|
Genetics, Medical
|
Concept
|
Length of Stay
|
Concept
|
Hemagglutinins, Viral
|
Concept
|
Lymphocyte Depletion
|
Concept
|
Mammary Glands, Animal
|
Concept
|
Hyperplasia
|
Concept
|
Microcephaly
|
Concept
|
Microfilament Proteins
|
Concept
|
Models, Molecular
|
Concept
|
Monoclonal Gammopathy of Undetermined Significance
|
Concept
|
Pilot Projects
|
Concept
|
Mice, Transgenic
|
Concept
|
Neutropenia
|
Concept
|
Mammary Tumor Virus, Mouse
|
Concept
|
Mastocytosis
|
Concept
|
Illinois
|
Concept
|
Immunoglobulin Isotypes
|
Concept
|
Pancreatic Neoplasms
|
Concept
|
Mesoderm
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mice, Nude
|
Concept
|
Repetitive Sequences, Nucleic Acid
|
Concept
|
Mitogens
|
Concept
|
Mitoxantrone
|
Concept
|
Morbidity
|
Concept
|
Cricetinae
|
Concept
|
Neutrophils
|
Concept
|
L-Lactate Dehydrogenase
|
Concept
|
Lactobacillus
|
Concept
|
Ovarian Neoplasms
|
Concept
|
Paraproteins
|
Concept
|
Mediastinal Neoplasms
|
Concept
|
Melphalan
|
Concept
|
Membrane Fusion
|
Concept
|
Morpholines
|
Concept
|
Muscle Proteins
|
Concept
|
Fibrosis
|
Concept
|
Plasma Cells
|
Concept
|
Protein Conformation
|
Concept
|
Protease Inhibitors
|
Concept
|
Histocompatibility Antigens
|
Concept
|
HLA Antigens
|
Concept
|
Recurrence
|
Concept
|
Receptors, Cell Surface
|
Concept
|
Registries
|
Concept
|
Risk Factors
|
Concept
|
Quality of Life
|
Concept
|
Intestinal Mucosa
|
Concept
|
Respiratory Tract Infections
|
Concept
|
Cohort Studies
|
Concept
|
Genes, ras
|
Concept
|
Regulatory Sequences, Nucleic Acid
|
Concept
|
Cadherins
|
Concept
|
Interleukin-6
|
Concept
|
Risk
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Texas
|
Concept
|
Sheep
|
Concept
|
Humans
|
Concept
|
Leukemia, Mast-Cell
|
Concept
|
Leukemia, Radiation-Induced
|
Concept
|
Leukocyte Count
|
Concept
|
Incidence
|
Concept
|
Cluster Analysis
|
Concept
|
Bone Marrow Transplantation
|
Concept
|
Tretinoin
|
Concept
|
Superoxides
|
Concept
|
United States
|
Concept
|
Syndrome
|
Concept
|
Caenorhabditis elegans
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
Germ-Line Mutation
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
Concept
|
Geriatric Assessment
|
Concept
|
Leukemia, Myeloid
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Rett Syndrome
|
Concept
|
Proportional Hazards Models
|
Concept
|
Risk Assessment
|
Concept
|
Disease Management
|
Concept
|
Insect Proteins
|
Concept
|
Myeloablative Agonists
|
Concept
|
Nuclear Localization Signals
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Vidarabine
|
Concept
|
Models, Animal
|
Concept
|
Receptors, Colony-Stimulating Factor
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
HMGA2 Protein
|
Concept
|
DNA Modification Methylases
|
Concept
|
Bias
|
Concept
|
Prevalence
|
Concept
|
Metabolic Clearance Rate
|
Concept
|
Zebrafish Proteins
|
Concept
|
Antigens, CD
|
Concept
|
Lymphoma
|
Concept
|
Mitochondria
|
Concept
|
Mortality
|
Concept
|
Multiple Myeloma
|
Concept
|
Leukemia, Myeloid, Acute
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
Stem Cell Transplantation
|
Concept
|
Mutagenesis, Site-Directed
|
Concept
|
Tacrolimus
|
Concept
|
Case-Control Studies
|
Concept
|
Antigens, Nuclear
|
Concept
|
In Situ Hybridization
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Protein Structure, Tertiary
|
Concept
|
Community-Acquired Infections
|
Concept
|
Methylation
|
Concept
|
Treatment Outcome
|
Concept
|
Neoplasm Metastasis
|
Concept
|
Neoplasm Recurrence, Local
|
Concept
|
Neoplasms, Experimental
|
Concept
|
Genomic Instability
|
Concept
|
Oligodeoxyribonucleotides
|
Concept
|
Consensus Sequence
|
Concept
|
Point Mutation
|
Concept
|
Bacteriophage T4
|
Concept
|
Gene Deletion
|
Concept
|
Sequence Deletion
|
Concept
|
Mice, Knockout
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
DNA, Complementary
|
Concept
|
Antigens, CD34
|
Concept
|
Disease Progression
|
Concept
|
Telomerase
|
Concept
|
Thrombospondin 1
|
Concept
|
Wnt1 Protein
|
Concept
|
beta Catenin
|
Concept
|
Antineoplastic Agents, Alkylating
|
Concept
|
Smad1 Protein
|
Concept
|
Caspase 3
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
Concept
|
Mutation, Missense
|
Concept
|
Drosophila Proteins
|
Concept
|
Lymphocyte Count
|
Concept
|
CpG Islands
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Chromosomes, Artificial, Human
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
Concept
|
Myelopoiesis
|
Concept
|
Karyopherins
|
Concept
|
DNA Repair Enzymes
|
Concept
|
Histone Code
|
Concept
|
Microarray Analysis
|
Concept
|
Response Elements
|
Concept
|
Proto-Oncogene Proteins c-kit
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
Concept
|
Amino Acid Motifs
|
Concept
|
Catalytic Domain
|
Concept
|
Databases, Genetic
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
Concept
|
Wnt Proteins
|
Concept
|
Phosphopyruvate Hydratase
|
Concept
|
Postoperative Complications
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Mice
|
Concept
|
Caspase 8
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Severity of Illness Index
|
Concept
|
RNA, Messenger
|
Concept
|
Mastocytosis, Systemic
|
Concept
|
Sulfonamides
|
Concept
|
Transfer RNA Aminoacylation
|
Concept
|
Donor Selection
|
Concept
|
Chimerism
|
Concept
|
Preoperative Period
|
Concept
|
Tetrasomy
|
Concept
|
GATA1 Transcription Factor
|
Concept
|
Rats
|
Concept
|
Kruppel-Like Transcription Factors
|
Concept
|
Real-Time Polymerase Chain Reaction
|
Concept
|
Antibodies, Monoclonal, Humanized
|
Concept
|
Valproic Acid
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Blotting, Western
|
Concept
|
Protein Interaction Domains and Motifs
|
Concept
|
Leukemia, Promyelocytic, Acute
|
Concept
|
Toll-Like Receptor 2
|
Concept
|
Survival Analysis
|
Concept
|
Lentivirus
|
Concept
|
DNA Copy Number Variations
|
Concept
|
Lymphoma, B-Cell
|
Concept
|
Reproducibility of Results
|
Concept
|
Leukemia, Myelomonocytic, Chronic
|
Concept
|
Gene Expression Regulation, Leukemic
|
Concept
|
Survival Rate
|
Concept
|
Codon, Nonsense
|
Concept
|
Fusion Proteins, bcr-abl
|
Concept
|
Lymphocyte Subsets
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
Concept
|
Zinc Fingers
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
Concept
|
CD3 Complex
|
Concept
|
Leukemic Infiltration
|
Concept
|
DNA Methylation
|
Concept
|
Hemagglutinin Glycoproteins, Influenza Virus
|
Concept
|
Karnofsky Performance Status
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Validation Studies as Topic
|
Concept
|
Xenograft Model Antitumor Assays
|
Concept
|
Germinal Center
|
Concept
|
Cell Lineage
|
Concept
|
Hematologic Neoplasms
|
Concept
|
Histone Demethylases
|
Concept
|
Histone Deacetylase Inhibitors
|
Concept
|
alpha Karyopherins
|
Concept
|
Tandem Repeat Sequences
|
Concept
|
Acute Kidney Injury
|
Concept
|
DNA Mismatch Repair
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Precision Medicine
|
Concept
|
Haploinsufficiency
|
Concept
|
Multiplex Polymerase Chain Reaction
|
Concept
|
RNA, Small Interfering
|
Concept
|
Cord Blood Stem Cell Transplantation
|
Concept
|
Molecular Sequence Annotation
|
Concept
|
Microfluidics
|
Concept
|
Tissue Array Analysis
|
Concept
|
Methyl-CpG-Binding Protein 2
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
Concept
|
fms-Like Tyrosine Kinase 3
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
Induced Pluripotent Stem Cells
|
Concept
|
Asymptomatic Diseases
|
Concept
|
Chromosome Aberrations
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Cytosine
|
Concept
|
Disease Models, Animal
|
Concept
|
Doxorubicin
|
Concept
|
Enhancer Elements, Genetic
|
Concept
|
Follow-Up Studies
|
Concept
|
Genetic Counseling
|
Concept
|
Genetic Testing
|
Concept
|
Hemoglobinuria, Paroxysmal
|
Concept
|
Injections, Subcutaneous
|
Concept
|
Liver Diseases
|
Concept
|
Lymphocyte Activation
|
Concept
|
Lymphoma, Non-Hodgkin
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Models, Biological
|
Concept
|
Monocytes
|
Concept
|
Neoplasm Invasiveness
|
Concept
|
Neuroblastoma
|
Concept
|
Predictive Value of Tests
|
Concept
|
Prospective Studies
|
Concept
|
Histone-Lysine N-Methyltransferase
|
Concept
|
Proto-Oncogenes
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Retrospective Studies
|
Concept
|
Staining and Labeling
|
Concept
|
Translocation, Genetic
|
Concept
|
World Health Organization
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
Concept
|
Immunophenotyping
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
Concept
|
Cytokines
|
Concept
|
Li-Fraumeni Syndrome
|
Concept
|
Conserved Sequence
|
Concept
|
DNA Primers
|
Concept
|
Neoplasm, Residual
|
Concept
|
Disease-Free Survival
|
Concept
|
Chromosome Breakage
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Cytogenetic Analysis
|
Concept
|
Databases, Nucleic Acid
|
Concept
|
MicroRNAs
|
Concept
|
Chromosomes, Human, X
|
Concept
|
5-Methylcytosine
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Molecular Dynamics Simulation
|
Academic Article
|
TTID: A novel gene at 5q31 encoding a protein with titin-like features.
|
Academic Article
|
Molecular characterization of KLHL3, a human homologue of the Drosophila kelch gene.
|
Academic Article
|
cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins.
|
Academic Article
|
Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.
|
Academic Article
|
Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
|
Academic Article
|
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
|
Academic Article
|
Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins.
|
Academic Article
|
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia.
|
Academic Article
|
Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues.
|
Academic Article
|
Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia.
|
Academic Article
|
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
Academic Article
|
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
|
Academic Article
|
Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
|
Academic Article
|
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
|
Academic Article
|
Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine.
|
Academic Article
|
The use of hypomethylating agents in the treatment of hematologic malignancies.
|
Academic Article
|
DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation.
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
Academic Article
|
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
|
Academic Article
|
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.
|
Academic Article
|
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
|
Academic Article
|
Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.
|
Academic Article
|
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
|
Academic Article
|
Molecular biology. Preference by exclusion.
|
Academic Article
|
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
|
Academic Article
|
Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia.
|
Academic Article
|
An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
|
Academic Article
|
Dnmt3a is essential for hematopoietic stem cell differentiation.
|
Academic Article
|
Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis.
|
Academic Article
|
Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
|
Academic Article
|
5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging.
|
Academic Article
|
Profiles in leukemia.
|
Academic Article
|
Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys.
|
Academic Article
|
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
|
Academic Article
|
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
|
Academic Article
|
Getting to the root of the stem cell in mutated chronic myeloid leukemia.
|
Academic Article
|
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
|
Academic Article
|
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.
|
Academic Article
|
Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
|
Academic Article
|
Defining the steps in a multistep mouse model for mammary carcinogenesis.
|
Academic Article
|
Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
|
Academic Article
|
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia.
|
Academic Article
|
High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis.
|
Academic Article
|
Perspectives and future directions for epigenetics in hematology.
|
Academic Article
|
Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traits.
|
Academic Article
|
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
|
Academic Article
|
Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
|
Academic Article
|
Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes.
|
Academic Article
|
Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
Academic Article
|
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies.
|
Academic Article
|
Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes.
|
Academic Article
|
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.
|
Academic Article
|
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
|
Academic Article
|
Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer.
|
Academic Article
|
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.
|
Academic Article
|
New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine.
|
Academic Article
|
Inherited predisposition to acute myeloid leukemia.
|
Academic Article
|
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
|
Academic Article
|
Alterations of 5-hydroxymethylcytosine in human cancers.
|
Academic Article
|
Large conserved domains of low DNA methylation maintained by Dnmt3a.
|
Academic Article
|
DNMT3B7 expression promotes tumor progression to a more aggressive phenotype in breast cancer cells.
|
Academic Article
|
The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.
|
Academic Article
|
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.
|
Academic Article
|
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
|
Academic Article
|
The mechanistic role of DNA methylation in myeloid leukemogenesis.
|
Academic Article
|
Linking the genetic architecture of cytosine modifications with human complex traits.
|
Academic Article
|
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.
|
Academic Article
|
5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.
|
Academic Article
|
Characterization of CpG sites that escape methylation on the inactive human X-chromosome.
|
Academic Article
|
DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID.
|
Academic Article
|
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
|
Academic Article
|
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
|
Academic Article
|
Epigenetic Control of Apolipoprotein E Expression Mediates Gender-Specific Hematopoietic Regulation.
|
Academic Article
|
Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.
|
Academic Article
|
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
|
Academic Article
|
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes.
|
Academic Article
|
Corrigendum: TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
|
Academic Article
|
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.
|
Academic Article
|
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
|
Academic Article
|
Erratum to "5-hydroxymethylcytosine in cancer: Significance in diagnosis and therapy" [Cancer Genet 208 (2015):167-177].
|
Academic Article
|
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.
|
Academic Article
|
Genetic predisposition to leukemia and other hematologic malignancies.
|
Academic Article
|
Cytogenetic responses to a 5-day dosing schedule of decitabine in patients (Pts) with myelodysplastic syndromes (MDS).
|
Academic Article
|
A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS).
|
Academic Article
|
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.
|
Academic Article
|
Recognition of familial myeloid neoplasia in adults.
|
Academic Article
|
Therapy-related myeloid neoplasms: when genetics and environment collide.
|
Academic Article
|
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host.
|
Academic Article
|
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
|
Academic Article
|
MBD4: guardian of the epigenetic galaxy.
|
Academic Article
|
Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways.
|
Academic Article
|
Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4+ and CD8+ T-lymphocytes.
|
Academic Article
|
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
|
Academic Article
|
Somatic mutation panels: Time to clear their names.
|
Academic Article
|
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.
|
Academic Article
|
FouNdER mutations confer risk for leukemias.
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
Academic Article
|
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
|
Academic Article
|
MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome.
|
Academic Article
|
HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia.
|
Academic Article
|
Regulation of telomeric function by DNA methylation differs between humans and mice.
|
Academic Article
|
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.
|
Academic Article
|
Identifying potential germline variants from sequencing hematopoietic malignancies.
|
Academic Article
|
Identifying potential germline variants from sequencing hematopoietic malignancies.
|
Academic Article
|
RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.
|
Academic Article
|
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.
|
Academic Article
|
MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.
|
Academic Article
|
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
|
Academic Article
|
Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation.
|
Academic Article
|
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
|
Academic Article
|
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers.
|
Concept
|
Clinical Decision-Making
|
Concept
|
Imatinib Mesylate
|
Concept
|
Filgrastim
|
Concept
|
Bortezomib
|
Concept
|
N-Myc Proto-Oncogene Protein
|
Concept
|
MDS1 and EVI1 Complex Locus Protein
|
Concept
|
Alemtuzumab
|
Concept
|
CCCTC-Binding Factor
|
Concept
|
Kruppel-Like Factor 6
|
Concept
|
DNA (Cytosine-5-)-Methyltransferase 1
|
Concept
|
Proteasome Inhibitors
|
Concept
|
Polycomb Repressive Complex 2
|
Concept
|
Carcinogenesis
|
Concept
|
Connectin
|
Concept
|
Patient-Specific Modeling
|
Grant
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
Grant
|
A chemical crosslinking strategy to determine DNA methylating protein complexes
|
Grant
|
Epigenetic and Genetic Dissection of Drug Response
|